SOURCE: Equity News Circuit

Equity News Circuit

January 24, 2013 08:45 ET

Free Research Reports on DGX, MTG, SNV and THLD Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwire - Jan 24, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Quest Diagnostics Inc. (NYSE: DGX) shares fell 5.5 percent on nearly four-times the average daily volume Wednesday. The company reported revenues from continuing operations totaled $1.8 billion in the fourth quarter, a decrease of 4 percent from a year ago.

Find out more about Quest Diagnostics including full access to the free equity report at: www.BedfordReport.com/DGX

MGIC Investment Corp. (NYSE: MTG) shares surged 8.4 percent on nearly twice the average daily volume Wednesday. The company has benefitted from the recent surge in U.S. home prices. Home prices gained 7.4 percent year-over-year in November, which was the largest gain seen in 6.5 years.

Find out more about MGIC Investment including full access to the free equity report at: www.BedfordReport.com/MTG

Synovus Financial Corp. (NYSE: SNV) shares declined 4 percent on more than twice the average daily volume Wednesday, despite posting an increase in fourth-quarter profit a day earlier. Analysts at both Morgan Stanley and Bernstein have recently downgraded their ratings on the company.

Find out more about Synovus Financial including full access to the free equity report at: www.BedfordReport.com/SNV

Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) shares soared 20 percent on over four-times the average daily volume Wednesday. Threshold is a clinical stage biopharmaceutical company focused on the discovery and development of cancer therapeutics based on a novel and powerful approach of targeting tumor hypoxia.

Find out more about Threshold Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/THLD

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information